Global private equity and venture capital news and research

Sequoia-backed Acton agrees $135m sale to strategic buyer Meda

2 Sep 2013

asthma inhaler health medicalSequoia Capital-backed asthma drug developer Acton Pharmaceuticals has been bought by international speciality pharmaceutical company Meda in a $135m deal.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016